Update: SAHPRA Approves Lenacapavir For HIV Prevention
SAHPRA Approves Lenacapavir For HIV Prevention SAHPRA's approval for lenacapavir is crucial for the country to begin drug rollout, expected by April 2026. In other news, communities…
SAHPRA Approves Lenacapavir For HIV Prevention SAHPRA's approval for lenacapavir is crucial for the country to begin drug rollout, expected by April 2026. In other news, communities…
Guard Therapeutics Announces Top-Line Results from Phase 2b POINTER Study Guard Therapeutics (publ) announced top-line results from the Ph…
Teachers Licensing Initiative to Uphold Education Standards The Botswana Teaching Professionals Councils (BOTEPCO) has launched a teacher …
SAHPRA Approves Groundbreaking HIV Prevention Injection The South African Health Products Regulatory Authority (SAHPRA) has approved a new…
Nokia, Ericsson and Fraunhofer Partnership for NextGen Video Compression Nokia, Ericsson, and Germany's Fraunhofer Heinrich Hertz Institut…
Bulls Shake Off Illness to Claim ALM Win Over Reds Macarthur FC have defeated Adelaide for their first victory of the A-League Men season,…
DAH Solar Showcases Innovative Solutions in Uzbekistan DAH Solar participated in the 2025 Uzbekistan energy expo in Tashkent, showcasing i…
Hyundai's New Venue Toughens Up With Boxier Looks The latest small SUV redesign adds screens, style, and space but skips any powertrain ch…
Artist-Designed Shade Structures in Phoenix, Arizona The city of Phoenix, Arizona, the hottest city in the US, is combating rising tempera…
AGRITECHNICA: Fraunhofer Presents Innovations for the Agriculture of Tomorrow Climate change, resource scarcity, and growing sustainabilit…
Compulsory Voting: A Remedy or Ruse for Democracy? The debate over compulsory voting revolves around a trade-off between participation and…